Celularity
CELU
26 hedge funds and large institutions have $2.96M invested in Celularity in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 4 closing their positions.
76% more call options, than puts
Call options by funds: $220K | Put options by funds: $125K
0.45% more ownership
Funds ownership: 3.89% → 4.34% (+0.45%)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
13% less funds holding
Funds holding: 30 → 26 (-4)
33% less capital invested
Capital invested by funds: $4.38M → $2.96M (-$1.42M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$400K |
| 2 |
BlackRock
New York
|
+$49.9K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$24K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$23.3K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$12.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$89K |
| 2 |
IA
IFP Advisors
Tampa,
Florida
|
-$41.7K |
| 3 |
Morgan Stanley
New York
|
-$29.5K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$17.1K |
| 5 |
Renaissance Technologies
New York
|
-$14.8K |
CELU Hedge Fund Activity: Q2 2024 in Review
26 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q2 2024, worth a combined $2.96M — down 33% from $4.38M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CELU and 0 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 7 added.
The largest buyer was Vanguard Group, adding an estimated $400K. The largest seller was Millennium Management, exiting entirely with an estimated $89K sold.
- 26 institutional investors held Celularity (CELU) as of Q2 2024, down from 30 in Q1 2024.
- Funds reported $2.96M of Celularity stock for Q2 2024, down 33% quarter-over-quarter.
- 0 funds opened new Celularity positions in Q2 2024 and 4 closed out, a net change of -4 holders.
- The largest Celularity buyer in Q2 2024 was Vanguard Group, an estimated $400K added.
- The largest Celularity seller in Q2 2024 was Millennium Management, an estimated $89K sold.
Based on aggregated 13F filings for Q2 2024.